Keith A. Goldan - 19 May 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
19 May 2025
Net transactions value
$0
Form type
4
Filing time
19 May 2025, 16:04:07 UTC
Previous filing
12 Feb 2025
Next filing
18 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Goldan Keith A. Chief Financial Officer 730 THIRD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger, Attorney-in-Fact 19 May 2025 0001495411

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Purchase +3,000 +3.3% 93,746 19 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase prices ranged from $8.8465 to $9.2825.